Singapore

Cordlife faces $5.45m in claims over 109 damaged cord blood units

It was ordered by the court to pay clients $50,000 per damaged unit.

SingLand unit to acquire Marina Square land parcel for $99.1m

The site, located at 6 Raffles Boulevard, spans approximately 3,992 square metres.

Inflation set to edge higher as 2026 pressures firm: analyst

On the domestic front, unit labour costs may stabilise at slightly higher levels.

Robojudge: Singapore to use AI in courtrooms for small claims

The tech needs safeguards to catch system hallucinations.

Will slower GDP growth and hiring weigh on HDB rentals?

The HDB rental market had stabilised in 2025, with leasing activity rising by 2.3% to roughly 37,500 contracts.

DBS forecasts GDP growth of 1.8% as Singapore shows measured resilience

On policy, DBS said authorities are likely to preserve buffers for counter-cyclical action. 

Singapore unveils $200m Talent Accelerator Programme

Industry calls for companies and professionals to apply will open in the first quarter of 2026.

Investment volumes in 2026 set to surpass 2025 levels

As 2025 YTD investments hit $28b, already beating last year’s $25b.

Far East Group closes down Penang subsidiary

FEE Penang had been dormant since selling its property in 2024.

Infinity Development Holdings raises $13.7m in SGX listing

Its post-placement market capitalisation is $123.5m.

HDB resale prices up 3% in November

A 5-room flat in Natura Loft was resold for over $1.63m.

MAS taps Manulife for $5b equity dev’t programme

The programme aims to boost investors and liquidity in the city-state’s market.

URA awards Bedok Rise site to Bellis Residential

It is a residential site with a gross floor area of 32,470 sq. m.

Industrial building lists for $13m in Tampines

It has a gross floor area of 70,859 sq. ft., a warehouse, and ancillary office spaces, CBRE said.

Singapore cracks global top 10 tech city ranking

Stability and infrastructure draw deep talent pools, solidifying the city's top 10 status.

The FTSE ST Industrials Index gains 36% as sector rerates

Hong Leong Asia was the top performer, gaining 141% year to date and attracting $53m in institutional inflows.